Rare diseases
Investigational molecules
Locations
353 conditions with trials, the busiest first
844 trials across Europe, recruiting first
Study on the Effectiveness of LY4100511 for Adults with Moderate-to-Severe Plaque Psoriasis
CzechiaStudy of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before
BulgariaStudy on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis
BulgariaStudy on the Effects of Povorcitinib for Patients with Prurigo Nodularis
AustriaStudy on the Effectiveness and Safety of ESK-001 and Apremilast for Adults with Moderate to Severe Plaque Psoriasis
BelgiumStudy on the Safety and Effectiveness of APG777 for Patients with Moderate-to-Severe Atopic Dermatitis
CzechiaStudy on Long-term Effects of Secukinumab in Patients with Moderate to Severe Hidradenitis Suppurativa
AustriaStudy on the Effects of PF-07275315 and PF-07264660 for Adults with Moderate to Severe Atopic Dermatitis
GermanyStudy on the Effects of Barzolvolimab for Patients with Prurigo Nodularis
CroatiaStudy Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines
BulgariaStudy on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
AustriaStudy on the Effects of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa
BelgiumThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
